Monogram Orthopaedics Statistics
Share Statistics
Monogram Orthopaedics has 34.31M shares outstanding. The number of shares has increased by 8.47% in one year.
| Shares Outstanding | 34.31M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 8.23% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 22.28M |
| Failed to Deliver (FTD) Shares | 4.16K |
| FTD / Avg. Volume | 4.56% |
Short Selling Information
The latest short interest is 256.64K, so 0.75% of the outstanding shares have been sold short.
| Short Interest | 256.64K |
| Short % of Shares Out | 0.75% |
| Short % of Float | 1.15% |
| Short Ratio (days to cover) | 3 |
Valuation Ratios
The PE ratio is -5.61 and the forward PE ratio is -4.62.
| PE Ratio | -5.61 |
| Forward PE | -4.62 |
| PS Ratio | 211.2 |
| Forward PS | 4.1 |
| PB Ratio | 5.75 |
| P/FCF Ratio | -5.67 |
| PEG Ratio | n/a |
Enterprise Valuation
Monogram Orthopaedics Inc. has an Enterprise Value (EV) of 63.99M.
| EV / Earnings | -4.66 |
| EV / Sales | 175.32 |
| EV / EBITDA | -3.8 |
| EV / EBIT | -3.71 |
| EV / FCF | -4.7 |
Financial Position
The company has a current ratio of 5.19, with a Debt / Equity ratio of 0.
| Current Ratio | 5.19 |
| Quick Ratio | 5.19 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -1.03% and return on capital (ROIC) is -124.33%.
| Return on Equity (ROE) | -1.03% |
| Return on Assets (ROA) | -0.83% |
| Return on Capital (ROIC) | -124.33% |
| Revenue Per Employee | 13.04K |
| Profits Per Employee | -490.90K |
| Employee Count | 28 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -29.43% in the last 52 weeks. The beta is 2.47, so Monogram Orthopaedics 's price volatility has been higher than the market average.
| Beta | 2.47 |
| 52-Week Price Change | -29.43% |
| 50-Day Moving Average | 2.34 |
| 200-Day Moving Average | 2.39 |
| Relative Strength Index (RSI) | 49.93 |
| Average Volume (20 Days) | 91.18K |
Income Statement
In the last 12 months, Monogram Orthopaedics had revenue of 365.00K and earned -13.75M in profits. Earnings per share was -0.61.
| Revenue | 365.00K |
| Gross Profit | 365.00K |
| Operating Income | -17.27M |
| Net Income | -13.75M |
| EBITDA | -16.86M |
| EBIT | -17.27M |
| Earnings Per Share (EPS) | -0.61 |
Balance Sheet
The company has 13.59M in cash and 491.99K in debt, giving a net cash position of 13.10M.
| Cash & Cash Equivalents | 13.59M |
| Total Debt | 491.99K |
| Net Cash | 13.10M |
| Retained Earnings | -51.51M |
| Total Assets | 20.22M |
| Working Capital | 16.08M |
Cash Flow
In the last 12 months, operating cash flow was -13.54M and capital expenditures -64.91K, giving a free cash flow of -13.61M.
| Operating Cash Flow | -13.54M |
| Capital Expenditures | -64.91K |
| Free Cash Flow | -13.61M |
| FCF Per Share | -0.61 |
Margins
Gross margin is 100%, with operating and profit margins of -4.73K% and -3.77K%.
| Gross Margin | 100% |
| Operating Margin | -4.73K% |
| Pretax Margin | -3.77K% |
| Profit Margin | -3.77K% |
| EBITDA Margin | -4.62K% |
| EBIT Margin | -4.73K% |
| FCF Margin | -3.73K% |
Dividends & Yields
MGRM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -24.7% |
| FCF Yield | -16.06% |
Analyst Forecast
The average price target for MGRM is $4, which is 61.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $4 |
| Price Target Difference | 61.9% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 12.75 |
| Piotroski F-Score | 3 |